Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2024-01-03 00:00:00 ET · period of report 2023-12-29 · accession 0001104659-24-000828 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-03 | 2023-12-29 | RYTM | Smith Hunter C | CFO | M - OptEx | $6.88 | +10.5K | 71.9K | +17% | +$72.2K |
| D | 2024-01-03 | 2023-12-29 | RYTM | Smith Hunter C | CFO | M - OptEx | $0.00 | -10.5K | 100.6K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-29 | M | A | 10,500 | $6.88 | 71,906 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-12-29 | M | D | 10,500 | $0.00 | 100,594 | D | $6.88 · — to 2027-08-08 | 10,500 Common Stock | (F1) The stock options is fully vested. |